![]() |
|
|
Department of Oncology, Albert Einstein Cancer Center, Montefiore Medical Center, Bronx, NY 10467
3To whom correspondence should be addressed.E-mail: augen{at}aecom.yu.edu.
The development of intestinal cancer involves complex genetic and epigenetic alterations in the intestinal mucosa. The principal signaling pathway responsible for the initiation of tumor formation, the APC-ß-catenin-TCF4 pathway, regulates both cell proliferation and colonic cell differentiation, but many other intrinsic and extrinsic signals also modulate these cell maturation pathways. The challenge is to understand how signaling and cell maturation are also modulated by nutritional agents. Through gene expression profiling, we have gained insight into the mechanisms by which short chain fatty acids regulate these pathways and the differences in response of gene programs, and of the specific regulation of the c-myc gene, to physiological regulators of intestinal cell maturation, such as butyrate, compared with pharmacological regulators such as the nonsteroidal antiinflammatory drug sulindac. Moreover, we used a combination of gene expression profiling of the response of cells in culture to sulindac and the response of the human mucosa in subjects treated with sulindac for 1 month, coupled with a mouse genetic model approach, to identify the cyclin dependent kinase inhibitor p21WAF1/Cip1 as an important suppressor of Apc-initiated intestinal tumor formation and a necessary component for tumor inhibition by sulindac. Finally, the mucous barrier, secreted by intestinal goblet cells, is the interface between the luminal contents and the intestinal mucosa. We generated a mouse genetic model with a targeted inactivation of the Muc2 gene that encodes the major intestinal mucin. These mice have no recognizable goblet cells due to the failure of cells to synthesize and store mucin. This leads to perturbations in intestinal crypt architecture, increased cellular proliferation and rates of cell migration, decreased apoptosis and development of adenomas and adenocarcinomas in the small and large intestine and the rectum.
KEY WORDS: intestinal cancer gene expression profiling mouse genetic models mucin cell maturation
This article has been cited by other articles:
![]() |
T. D. Allen, D. R. Moore, X. Wang, V. Casu, R. May, M. R. Lerner, C. Houchen, D. J. Brackett, and M. M. Huycke Dichotomous metabolism of Enterococcus faecalis induced by haematin starvation modulates colonic gene expression J. Med. Microbiol., October 1, 2008; 57(10): 1193 - 1204. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tong, Z. Yin, Z. Song, A. Dockendorff, C. Huang, J. Mariadason, R. A. Flavell, R. J. Davis, L. H. Augenlicht, and W. Yang c-Jun NH2-Terminal Kinase 1 Plays a Critical Role in Intestinal Homeostasis and Tumor Suppression Am. J. Pathol., July 1, 2007; 171(1): 297 - 303. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Parhar, K. A. Baer, K. Parker, and M. J. Ropeleski Short-chain fatty acid mediated phosphorylation of heat shock protein 25: effects on camptothecin-induced apoptosis Am J Physiol Gastrointest Liver Physiol, August 1, 2006; 291(2): G178 - G188. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yang, A. Velcich, I. Lozonschi, J. Liang, C. Nicholas, M. Zhuang, L. Bancroft, and L. H. Augenlicht Inactivation of p21WAF1/cip1 Enhances Intestinal Tumor Formation in Muc2-/- Mice Am. J. Pathol., April 1, 2005; 166(4): 1239 - 1246. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Huycke and H. R. Gaskins Commensal Bacteria, Redox Stress, and Colorectal Cancer: Mechanisms and Models Experimental Biology and Medicine, July 1, 2004; 229(7): 586 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-J. Liu, J. Zhang, S. Ramanan, J. Julian, D. D. Carson, and S. C. Hooi Heparin/heparan sulfate interacting protein plays a role in apoptosis induced by anticancer drugs Carcinogenesis, June 1, 2004; 25(6): 873 - 879. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Klampfer, J. Huang, T. Sasazuki, S. Shirasawa, and L. Augenlicht Inhibition of Interferon {gamma} Signaling by the Short Chain Fatty Acid Butyrate Mol. Cancer Res., September 1, 2003; 1(11): 855 - 862. [Abstract] [Full Text] [PDF] |
||||